# The Risk Stratification in Patients With Multiple Myeloma Based on Fluorescence Flow Cytometry Quantitative Determination of the Circulating Plasma Cells in the Peripheral Blood

> **NCT04242121** · — · TERMINATED · sponsor: **Ivan S Moiseev** · enrollment: 24 (actual)

## Conditions studied

- Myeloma Multiple

## Interventions

- **DIAGNOSTIC_TEST:** fluorescence flow cytometry

## Key facts

- **NCT ID:** NCT04242121
- **Lead sponsor:** Ivan S Moiseev
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-15
- **Primary completion:** 2024-05-06
- **Final completion:** 2024-05-06
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** poor recruitment
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04242121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04242121, "The Risk Stratification in Patients With Multiple Myeloma Based on Fluorescence Flow Cytometry Quantitative Determination of the Circulating Plasma Cells in the Peripheral Blood". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04242121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*